▶ 調査レポート

世界のパーキンソン病における脳深部刺激療法市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Deep Brain Stimulation in Parkinson's Disease Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のパーキンソン病における脳深部刺激療法市場規模・現状・予測(2021年-2027年) / Global Deep Brain Stimulation in Parkinson's Disease Market Size, Status and Forecast 2021-2027 / QFJ1-4100資料のイメージです。• レポートコード:QFJ1-4100
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、パーキンソン病における脳深部刺激療法の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(デュアルチャネル脳深部刺激装置、シングルチャネル脳深部刺激装置)、用途別市場規模(病院、神経科クリニック、研究センター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・パーキンソン病における脳深部刺激療法の市場動向
・企業の競争状況、市場シェア
・パーキンソン病における脳深部刺激療法の種類別市場規模と予測2016-2027(デュアルチャネル脳深部刺激装置、シングルチャネル脳深部刺激装置)
・パーキンソン病における脳深部刺激療法の用途別市場規模と予測2016-2027(病院、神経科クリニック、研究センター)
・パーキンソン病における脳深部刺激療法の北米市場規模2016-2027(アメリカ、カナダ)
・パーキンソン病における脳深部刺激療法の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・パーキンソン病における脳深部刺激療法のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・パーキンソン病における脳深部刺激療法の中南米市場規模2016-2027(メキシコ、ブラジル)
・パーキンソン病における脳深部刺激療法の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Aleva Neurotherapeutics SA、Beijing PINS Medical Co、Boston Scientific Corporation、Functional Neuromodulation Ltd、Medtronic、Neuronetics Inc.、NeuroPace Inc.、Nevro Corporation)
・結論

Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of a medical device called a neurostimulator (sometimes referred to as a “brain pacemaker”), which sends electrical impulses, through implanted electrodes, to specific targets in the brain. DBS is used to manage some of the symptoms of Parkinson’s Disease that cannot be adequately controlled with medications. It is recommended for people who have PD with motor fluctuations and tremor inadequately controlled by medication, or to those who are intolerant to medication, as long as they do not have severe neuropsychiatric problems.

Market Analysis and Insights: Global Deep Brain Stimulation in Parkinson’s Disease Market
The global Deep Brain Stimulation in Parkinson’s Disease market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Deep Brain Stimulation in Parkinson’s Disease market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Deep Brain Stimulation in Parkinson’s Disease market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Deep Brain Stimulation in Parkinson’s Disease market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Deep Brain Stimulation in Parkinson’s Disease market.

Global Deep Brain Stimulation in Parkinson’s Disease Scope and Market Size
Deep Brain Stimulation in Parkinson’s Disease market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Deep Brain Stimulation in Parkinson’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Dual Channel Deep brain Stimulator
Single Channel Deep brain Stimulator

Segment by Application
Hospitals
Neurology Clinics
Research Centers

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Aleva Neurotherapeutics SA
Beijing PINS Medical Co
Boston Scientific Corporation
Functional Neuromodulation Ltd
Medtronic
Neuronetics Inc.
NeuroPace Inc.
Nevro Corporation

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Deep Brain Stimulation in Parkinson’s Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Dual Channel Deep brain Stimulator
1.2.3 Single Channel Deep brain Stimulator
1.3 Market by Application
1.3.1 Global Deep Brain Stimulation in Parkinson’s Disease Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Neurology Clinics
1.3.4 Research Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Deep Brain Stimulation in Parkinson’s Disease Market Perspective (2016-2027)
2.2 Deep Brain Stimulation in Parkinson’s Disease Growth Trends by Regions
2.2.1 Deep Brain Stimulation in Parkinson’s Disease Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Deep Brain Stimulation in Parkinson’s Disease Historic Market Share by Regions (2016-2021)
2.2.3 Deep Brain Stimulation in Parkinson’s Disease Forecasted Market Size by Regions (2022-2027)
2.3 Deep Brain Stimulation in Parkinson’s Disease Industry Dynamic
2.3.1 Deep Brain Stimulation in Parkinson’s Disease Market Trends
2.3.2 Deep Brain Stimulation in Parkinson’s Disease Market Drivers
2.3.3 Deep Brain Stimulation in Parkinson’s Disease Market Challenges
2.3.4 Deep Brain Stimulation in Parkinson’s Disease Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Deep Brain Stimulation in Parkinson’s Disease Players by Revenue
3.1.1 Global Top Deep Brain Stimulation in Parkinson’s Disease Players by Revenue (2016-2021)
3.1.2 Global Deep Brain Stimulation in Parkinson’s Disease Revenue Market Share by Players (2016-2021)
3.2 Global Deep Brain Stimulation in Parkinson’s Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Deep Brain Stimulation in Parkinson’s Disease Revenue
3.4 Global Deep Brain Stimulation in Parkinson’s Disease Market Concentration Ratio
3.4.1 Global Deep Brain Stimulation in Parkinson’s Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Deep Brain Stimulation in Parkinson’s Disease Revenue in 2020
3.5 Deep Brain Stimulation in Parkinson’s Disease Key Players Head office and Area Served
3.6 Key Players Deep Brain Stimulation in Parkinson’s Disease Product Solution and Service
3.7 Date of Enter into Deep Brain Stimulation in Parkinson’s Disease Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Deep Brain Stimulation in Parkinson’s Disease Breakdown Data by Type
4.1 Global Deep Brain Stimulation in Parkinson’s Disease Historic Market Size by Type (2016-2021)
4.2 Global Deep Brain Stimulation in Parkinson’s Disease Forecasted Market Size by Type (2022-2027)

5 Deep Brain Stimulation in Parkinson’s Disease Breakdown Data by Application
5.1 Global Deep Brain Stimulation in Parkinson’s Disease Historic Market Size by Application (2016-2021)
5.2 Global Deep Brain Stimulation in Parkinson’s Disease Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Deep Brain Stimulation in Parkinson’s Disease Market Size (2016-2027)
6.2 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Type
6.2.1 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2016-2021)
6.2.2 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2022-2027)
6.2.3 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2016-2027)
6.3 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Application
6.3.1 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2016-2021)
6.3.2 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2022-2027)
6.3.3 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2016-2027)
6.4 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Country
6.4.1 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Country (2016-2021)
6.4.2 North America Deep Brain Stimulation in Parkinson’s Disease Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size (2016-2027)
7.2 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Type
7.2.1 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2016-2021)
7.2.2 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2022-2027)
7.2.3 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2016-2027)
7.3 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Application
7.3.1 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2016-2021)
7.3.2 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2022-2027)
7.3.3 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2016-2027)
7.4 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Country
7.4.1 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Country (2016-2021)
7.4.2 Europe Deep Brain Stimulation in Parkinson’s Disease Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size (2016-2027)
8.2 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Type
8.2.1 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2016-2027)
8.3 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Application
8.3.1 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2016-2027)
8.4 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Region
8.4.1 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Deep Brain Stimulation in Parkinson’s Disease Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size (2016-2027)
9.2 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Type
9.2.1 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2016-2021)
9.2.2 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2022-2027)
9.2.3 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2016-2027)
9.3 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Application
9.3.1 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2016-2021)
9.3.2 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2022-2027)
9.3.3 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2016-2027)
9.4 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Country
9.4.1 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Country (2016-2021)
9.4.2 Latin America Deep Brain Stimulation in Parkinson’s Disease Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size (2016-2027)
10.2 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Type
10.2.1 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Type (2016-2027)
10.3 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Application
10.3.1 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Application (2016-2027)
10.4 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Country
10.4.1 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Deep Brain Stimulation in Parkinson’s Disease Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Deep Brain Stimulation in Parkinson’s Disease Introduction
11.1.4 Abbott Revenue in Deep Brain Stimulation in Parkinson’s Disease Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Aleva Neurotherapeutics SA
11.2.1 Aleva Neurotherapeutics SA Company Details
11.2.2 Aleva Neurotherapeutics SA Business Overview
11.2.3 Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson’s Disease Introduction
11.2.4 Aleva Neurotherapeutics SA Revenue in Deep Brain Stimulation in Parkinson’s Disease Business (2016-2021)
11.2.5 Aleva Neurotherapeutics SA Recent Development
11.3 Beijing PINS Medical Co
11.3.1 Beijing PINS Medical Co Company Details
11.3.2 Beijing PINS Medical Co Business Overview
11.3.3 Beijing PINS Medical Co Deep Brain Stimulation in Parkinson’s Disease Introduction
11.3.4 Beijing PINS Medical Co Revenue in Deep Brain Stimulation in Parkinson’s Disease Business (2016-2021)
11.3.5 Beijing PINS Medical Co Recent Development
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Details
11.4.2 Boston Scientific Corporation Business Overview
11.4.3 Boston Scientific Corporation Deep Brain Stimulation in Parkinson’s Disease Introduction
11.4.4 Boston Scientific Corporation Revenue in Deep Brain Stimulation in Parkinson’s Disease Business (2016-2021)
11.4.5 Boston Scientific Corporation Recent Development
11.5 Functional Neuromodulation Ltd
11.5.1 Functional Neuromodulation Ltd Company Details
11.5.2 Functional Neuromodulation Ltd Business Overview
11.5.3 Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson’s Disease Introduction
11.5.4 Functional Neuromodulation Ltd Revenue in Deep Brain Stimulation in Parkinson’s Disease Business (2016-2021)
11.5.5 Functional Neuromodulation Ltd Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Deep Brain Stimulation in Parkinson’s Disease Introduction
11.6.4 Medtronic Revenue in Deep Brain Stimulation in Parkinson’s Disease Business (2016-2021)
11.6.5 Medtronic Recent Development
11.7 Neuronetics Inc.
11.7.1 Neuronetics Inc. Company Details
11.7.2 Neuronetics Inc. Business Overview
11.7.3 Neuronetics Inc. Deep Brain Stimulation in Parkinson’s Disease Introduction
11.7.4 Neuronetics Inc. Revenue in Deep Brain Stimulation in Parkinson’s Disease Business (2016-2021)
11.7.5 Neuronetics Inc. Recent Development
11.8 NeuroPace Inc.
11.8.1 NeuroPace Inc. Company Details
11.8.2 NeuroPace Inc. Business Overview
11.8.3 NeuroPace Inc. Deep Brain Stimulation in Parkinson’s Disease Introduction
11.8.4 NeuroPace Inc. Revenue in Deep Brain Stimulation in Parkinson’s Disease Business (2016-2021)
11.8.5 NeuroPace Inc. Recent Development
11.9 Nevro Corporation
11.9.1 Nevro Corporation Company Details
11.9.2 Nevro Corporation Business Overview
11.9.3 Nevro Corporation Deep Brain Stimulation in Parkinson’s Disease Introduction
11.9.4 Nevro Corporation Revenue in Deep Brain Stimulation in Parkinson’s Disease Business (2016-2021)
11.9.5 Nevro Corporation Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Deep Brain Stimulation in Parkinson's Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Dual Channel Deep brain Stimulator
Table 3. Key Players of Single Channel Deep brain Stimulator
Table 4. Global Deep Brain Stimulation in Parkinson's Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Deep Brain Stimulation in Parkinson's Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Deep Brain Stimulation in Parkinson's Disease Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Regions (2016-2021)
Table 8. Global Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Regions (2022-2027)
Table 10. Deep Brain Stimulation in Parkinson's Disease Market Trends
Table 11. Deep Brain Stimulation in Parkinson's Disease Market Drivers
Table 12. Deep Brain Stimulation in Parkinson's Disease Market Challenges
Table 13. Deep Brain Stimulation in Parkinson's Disease Market Restraints
Table 14. Global Deep Brain Stimulation in Parkinson's Disease Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Players (2016-2021)
Table 16. Global Top Deep Brain Stimulation in Parkinson's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deep Brain Stimulation in Parkinson's Disease as of 2020)
Table 17. Ranking of Global Top Deep Brain Stimulation in Parkinson's Disease Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Deep Brain Stimulation in Parkinson's Disease Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Deep Brain Stimulation in Parkinson's Disease Product Solution and Service
Table 21. Date of Enter into Deep Brain Stimulation in Parkinson's Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Type (2016-2021)
Table 25. Global Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Deep Brain Stimulation in Parkinson's Disease Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Application (2016-2021)
Table 29. Global Deep Brain Stimulation in Parkinson's Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Deep Brain Stimulation in Parkinson's Disease Product
Table 64. Abbott Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Aleva Neurotherapeutics SA Company Details
Table 67. Aleva Neurotherapeutics SA Business Overview
Table 68. Aleva Neurotherapeutics SA Deep Brain Stimulation in Parkinson's Disease Product
Table 69. Aleva Neurotherapeutics SA Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 70. Aleva Neurotherapeutics SA Recent Development
Table 71. Beijing PINS Medical Co Company Details
Table 72. Beijing PINS Medical Co Business Overview
Table 73. Beijing PINS Medical Co Deep Brain Stimulation in Parkinson's Disease Product
Table 74. Beijing PINS Medical Co Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 75. Beijing PINS Medical Co Recent Development
Table 76. Boston Scientific Corporation Company Details
Table 77. Boston Scientific Corporation Business Overview
Table 78. Boston Scientific Corporation Deep Brain Stimulation in Parkinson's Disease Product
Table 79. Boston Scientific Corporation Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 80. Boston Scientific Corporation Recent Development
Table 81. Functional Neuromodulation Ltd Company Details
Table 82. Functional Neuromodulation Ltd Business Overview
Table 83. Functional Neuromodulation Ltd Deep Brain Stimulation in Parkinson's Disease Product
Table 84. Functional Neuromodulation Ltd Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 85. Functional Neuromodulation Ltd Recent Development
Table 86. Medtronic Company Details
Table 87. Medtronic Business Overview
Table 88. Medtronic Deep Brain Stimulation in Parkinson's Disease Product
Table 89. Medtronic Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 90. Medtronic Recent Development
Table 91. Neuronetics Inc. Company Details
Table 92. Neuronetics Inc. Business Overview
Table 93. Neuronetics Inc. Deep Brain Stimulation in Parkinson's Disease Product
Table 94. Neuronetics Inc. Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 95. Neuronetics Inc. Recent Development
Table 96. NeuroPace Inc. Company Details
Table 97. NeuroPace Inc. Business Overview
Table 98. NeuroPace Inc. Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 99. NeuroPace Inc. Recent Development
Table 100. Nevro Corporation Company Details
Table 101. Nevro Corporation Business Overview
Table 102. Nevro Corporation Deep Brain Stimulation in Parkinson's Disease Product
Table 103. Nevro Corporation Revenue in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021) & (US$ Million)
Table 104. Nevro Corporation Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Type: 2020 VS 2027
Figure 2. Dual Channel Deep brain Stimulator Features
Figure 3. Single Channel Deep brain Stimulator Features
Figure 4. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Neurology Clinics Case Studies
Figure 7. Research Centers Case Studies
Figure 8. Deep Brain Stimulation in Parkinson's Disease Report Years Considered
Figure 9. Global Deep Brain Stimulation in Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Deep Brain Stimulation in Parkinson's Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Regions: 2020 VS 2027
Figure 12. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Regions (2022-2027)
Figure 13. Global Deep Brain Stimulation in Parkinson's Disease Market Share by Players in 2020
Figure 14. Global Top Deep Brain Stimulation in Parkinson's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deep Brain Stimulation in Parkinson's Disease as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Deep Brain Stimulation in Parkinson's Disease Revenue in 2020
Figure 16. Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Type (2016-2021)
Figure 17. Global Deep Brain Stimulation in Parkinson's Disease Revenue Market Share by Type (2022-2027)
Figure 18. North America Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Deep Brain Stimulation in Parkinson's Disease Market Share by Type (2016-2027)
Figure 20. North America Deep Brain Stimulation in Parkinson's Disease Market Share by Application (2016-2027)
Figure 21. North America Deep Brain Stimulation in Parkinson's Disease Market Share by Country (2016-2027)
Figure 22. United States Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Deep Brain Stimulation in Parkinson's Disease Market Share by Type (2016-2027)
Figure 26. Europe Deep Brain Stimulation in Parkinson's Disease Market Share by Application (2016-2027)
Figure 27. Europe Deep Brain Stimulation in Parkinson's Disease Market Share by Country (2016-2027)
Figure 28. Germany Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Deep Brain Stimulation in Parkinson's Disease Market Share by Region (2016-2027)
Figure 38. China Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Deep Brain Stimulation in Parkinson's Disease Market Share by Type (2016-2027)
Figure 46. Latin America Deep Brain Stimulation in Parkinson's Disease Market Share by Application (2016-2027)
Figure 47. Latin America Deep Brain Stimulation in Parkinson's Disease Market Share by Country (2016-2027)
Figure 48. Mexico Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Deep Brain Stimulation in Parkinson's Disease Market Share by Country (2016-2027)
Figure 54. Turkey Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Deep Brain Stimulation in Parkinson's Disease Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021)
Figure 58. Aleva Neurotherapeutics SA Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021)
Figure 59. Beijing PINS Medical Co Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021)
Figure 60. Boston Scientific Corporation Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021)
Figure 61. Functional Neuromodulation Ltd Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021)
Figure 62. Medtronic Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021)
Figure 63. Neuronetics Inc. Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021)
Figure 64. NeuroPace Inc. Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021)
Figure 65. Nevro Corporation Revenue Growth Rate in Deep Brain Stimulation in Parkinson's Disease Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed